Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Odyssey Health, Inc.ODYY · Entity 8618 | Chief Operating Officer | June 28, 2024 | July 16, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Odyssey Health, Inc.
Report date June 28, 2024 · Filed July 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to BuySEC Table II · derivative / convertible security · Conversion / exercise price $0.10 · Expires 2034-06-27 | Direct | 250,000 |
Reported balance
After 2024-06-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-06-28 · Grant · Acquired 250,000 · Balance 250,000 F1: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2024 Filed Jul 16, 2024 17:10 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy · Derivative | 250,000 | $0.10 Strike: $0.10 | $25,000.00 |
DisclosureSEC source: 0001683168-24-004901 · ownership.xml · derivative · entry 1 Gironda Gregory W · CIK 0001955096 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2034-06-27 F1 · shares: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025. F1 · derivative.underlying_shares: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025. F1 · balance_after: The options vest 50,000 immediately; 50,000 vest on July 31, 2024; 50,000 vest on October 31, 2024; 50,000 vest on January 31, 2025; and 50,000 vest on April 30, 2025. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 17:10 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 37,500 | $0.09 Strike: $0.09 | $3,187.50 |
DisclosureSEC source: 0001683168-24-000341 · ownership.xml · derivative · entry 1 Gironda Gregory W · CIK 0001955096 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2034-01-15 F1 · shares: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024. F1 · derivative.underlying_shares: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024. F1 · balance_after: The non-qualified stock options are granted outside the Amended and Restated 2021 Omnibus Stock Incentive Plan, vesting immediately and the exercise price is the closing price on the date of the grant, January 16, 2024. Read SEC document |
| December 29, 2023 Filed Jan 2, 2024 17:10 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.10 Strike: $0.10 | $20,000.00 |
DisclosureSEC source: 0001683168-24-000023 · ownership.xml · derivative · entry 1 Gironda Gregory W · CIK 0001955096 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2033-12-28 F1 · shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023 F1 · derivative.underlying_shares: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023 F1 · balance_after: The options vest immediately and the exercise price is the closing price on the date of the grant, December 29, 2023 Read SEC document |
| November 01, 2022 Filed Nov 23, 2022 16:04 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option - Right to buy · Derivative | 475,000 | $0.25 Strike: $0.25 | $118,750.00 |
DisclosureSEC source: 0001683168-22-008024 · ownership.xml · derivative · entry 2 Gironda Gregory W · CIK 0001955096 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 475,000 shares Expires 2032-10-31 F1 · date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE. F1 · deemedExecutionDate: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE. F1 · derivative.exercise_date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE. F1 · balance_after: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE. Read SEC document |
| November 01, 2022 Filed Nov 23, 2022 16:04 UTC | Odyssey Health, Inc. ODYY · Entity 8618 | GrantStock Option - Right to buy · Derivative | 125,000 | $0.25 Strike: $0.25 | $31,250.00 |
DisclosureSEC source: 0001683168-22-008024 · ownership.xml · derivative · entry 1 Gironda Gregory W · CIK 0001955096 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2032-10-31 F1 · date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE. F1 · derivative.exercise_date: Vesting is as follows: 125,000 vest upon signing of this agreement; 300,000 vest upon a financing by the Company in the amount of $5,000,000 or more; 175,000 vest upon the listing of the Company on a national exchange such as Nasdaq or the NYSE. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.